Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1998 Nov;35(11):915–919. doi: 10.1136/jmg.35.11.915

Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families.

M Sato 1, S Matsubara 1, A Miyauchi 1, H Ohye 1, H Imachi 1, K Murao 1, J Takahara 1
PMCID: PMC1051484  PMID: 9832038

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by tumours of the parathyroid glands, the anterior pituitary, and endocrine pancreas. The MEN1 gene has recently been cloned and germline mutations have been identified in MEN1 patients in the United States, Canada, and Europe. We examined MEN1 gene mutations in MEN1 and MEN1 related cases in eight unrelated Japanese families. These families include five familial MEN1 (FMEN1), two sporadic MEN1 (SMEN1), and one familial hyperparathyroidism (FHP). Direct sequence analysis of the protein coding regions was carried out in all the probands. We identified six different heterozygous mutations in the coding region, of which five were novel, including one missense mutation (E45G) in both FMEN1 and SMEN1, three deletions (569del, 711del, and 1350del3) in FMEN1 and FHP, and two nonsense mutations (R29X and Y312X) in FMEN1 and SMEN1. Only one of these mutations (Y312X) has previously been reported. One proband with FMEN1 had no mutation in the entire exon sequence including the 5' and 3' untranslated regions. A restriction digestion analysis of 19 relatives from the five families showed a close correlation between the existence of the MEN1 gene mutation and disease onset. Four different polymorphisms, including two novel ones, were identified. These findings imply that a diversity of MEN1 gene mutations exists in Japanese MEN1 and MEN1 related disease, suggesting that analysis of the entire coding region of the MEN1 gene is required for genetic counselling in Japan.

Full text

PDF
915

Images in this article

917Image
on p.917
917Image
on p.917

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal S. K., Kester M. B., Debelenko L. V., Heppner C., Emmert-Buck M. R., Skarulis M. C., Doppman J. L., Kim Y. S., Lubensky I. A., Zhuang Z. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997 Jul;6(7):1169–1175. doi: 10.1093/hmg/6.7.1169. [DOI] [PubMed] [Google Scholar]
  2. Byström C., Larsson C., Blomberg C., Sandelin K., Falkmer U., Skogseid B., Oberg K., Werner S., Nordenskjöld M. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1968–1972. doi: 10.1073/pnas.87.5.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chandrasekharappa S. C., Guru S. C., Manickam P., Olufemi S. E., Collins F. S., Emmert-Buck M. R., Debelenko L. V., Zhuang Z., Lubensky I. A., Liotta L. A. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997 Apr 18;276(5311):404–407. doi: 10.1126/science.276.5311.404. [DOI] [PubMed] [Google Scholar]
  4. Friedman E., De Marco L., Gejman P. V., Norton J. A., Bale A. E., Aurbach G. D., Spiegel A. M., Marx S. J. Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res. 1992 Dec 15;52(24):6804–6809. [PubMed] [Google Scholar]
  5. Friedman E., Sakaguchi K., Bale A. E., Falchetti A., Streeten E., Zimering M. B., Weinstein L. S., McBride W. O., Nakamura Y., Brandi M. L. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med. 1989 Jul 27;321(4):213–218. doi: 10.1056/NEJM198907273210402. [DOI] [PubMed] [Google Scholar]
  6. Giraud S., Choplin H., Teh B. T., Lespinasse J., Jouvet A., Labat-Moleur F., Lenoir G., Hamon B., Hamon P., Calender A. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J Clin Endocrinol Metab. 1997 Oct;82(10):3487–3492. doi: 10.1210/jcem.82.10.4052. [DOI] [PubMed] [Google Scholar]
  7. Haliassos A., Chomel J. C., Grandjouan S., Kruh J., Kaplan J. C., Kitzis A. Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res. 1989 Oct 25;17(20):8093–8099. doi: 10.1093/nar/17.20.8093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heimdal K., Olsson H., Tretli S., Flodgren P., Børresen A. L., Fossa S. D. Familial testicular cancer in Norway and southern Sweden. Br J Cancer. 1996 Apr;73(7):964–969. doi: 10.1038/bjc.1996.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Horwitz M., Goode E. L., Jarvik G. P. Anticipation in familial leukemia. Am J Hum Genet. 1996 Nov;59(5):990–998. [PMC free article] [PubMed] [Google Scholar]
  10. Knudson A. G., Jr Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985 Apr;45(4):1437–1443. [PubMed] [Google Scholar]
  11. Larsson C., Skogseid B., Oberg K., Nakamura Y., Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 1988 Mar 3;332(6159):85–87. doi: 10.1038/332085a0. [DOI] [PubMed] [Google Scholar]
  12. Lemmens I., Van de Ven W. J., Kas K., Zhang C. X., Giraud S., Wautot V., Buisson N., De Witte K., Salandre J., Lenoir G. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet. 1997 Jul;6(7):1177–1183. doi: 10.1093/hmg/6.7.1177. [DOI] [PubMed] [Google Scholar]
  13. Marx S. J., Spiegel A. M., Levine M. A., Rizzoli R. E., Lasker R. D., Santora A. C., Downs R. W., Jr, Aurbach G. D. Familial hypocalciuric hypercalcemia: the relation to primary parathyroid hyperplasia. N Engl J Med. 1982 Aug 12;307(7):416–426. doi: 10.1056/NEJM198208123070707. [DOI] [PubMed] [Google Scholar]
  14. Mulligan L. M., Kwok J. B., Healey C. S., Elsdon M. J., Eng C., Gardner E., Love D. R., Mole S. E., Moore J. K., Papi L. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993 Jun 3;363(6428):458–460. doi: 10.1038/363458a0. [DOI] [PubMed] [Google Scholar]
  15. Presciuttini S., Varesco L., Sala P., Gismondi V., Rossetti C., Bafico A., Ferrara G. B., Bertario L. Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations. Ann Hum Genet. 1994 Oct;58(Pt 4):331–342. doi: 10.1111/j.1469-1809.1994.tb00730.x. [DOI] [PubMed] [Google Scholar]
  16. Trump D., Farren B., Wooding C., Pang J. T., Besser G. M., Buchanan K. D., Edwards C. R., Heath D. A., Jackson C. E., Jansen S. Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM. 1996 Sep;89(9):653–669. doi: 10.1093/qjmed/89.9.653. [DOI] [PubMed] [Google Scholar]
  17. WERMER P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954 Mar;16(3):363–371. doi: 10.1016/0002-9343(54)90353-8. [DOI] [PubMed] [Google Scholar]
  18. Yokote R., Sato M., Matsubara S., Ohye H., Niimi M., Murao K., Takahara J. Molecular cloning and gene expression of growth hormone-releasing peptide receptor in rat tissues. Peptides. 1998;19(1):15–20. doi: 10.1016/s0196-9781(97)00263-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES